Midgut Neuroendocrine Tumor — Trials

Midgut Neuroendocrine Tumor — Trials · CancerIndex

Clinical trials

Registered studies

6 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–4 of 4 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01841736	Pazopanib Hydrochloride in Treating Patients With Progressive Carcinoid Tumors	active not recruiting	Phase 2	171	National Cancer Institute (NCI)NIH	2	Aug 28, 2026	clinicaltrials
NCT03891784	Abemaciclib in Treating Patients With Advanced, Refractory, and Unresectable Digestive System Neuroendocrine Tumors	active not recruiting	Phase 2	20	University of WashingtonOTHER	1	Jan 14, 2026	clinicaltrials
NCT02651987	Efficacy and Safety Study in Pancreatic or Midgut Neuroendocrine Tumours Having Progressed Radiologically While Previously Treated With Lanreotide Autogel® 120 mg(CLARINET FORTE)	completed	Phase 2	99	IpsenINDUSTRY	10	Oct 3, 2022	clinicaltrials
NCT02358356	Capecitabine ON Temozolomide Radionuclide Therapy Octreotate Lutetium-177 NeuroEndocrine Tumours Study(CONTROL NETS)	completed

Data updated 22 days agoSource updated Aug 28, 2026source: clinicaltrials